Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple

Ruoqing Feng1, Lena Spieth1, Lu Liu1

  • 1Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany.

Immunity
|October 30, 2025
PubMed

Insights

Researchers mapped immune cells in active multiple sclerosis (MS) lesions, revealing lipid-metabolizing microglia drive persistent neuroinflammation. Targeting lipid metabolism reduced inflammation and demyelination in mouse models, offering new therapeutic avenues for MS.

Area of Science:

  • Neuroimmunology
  • Cellular and Molecular Neuroscience

Background:

  • Compartmentalized inflammation drives multiple sclerosis (MS) progression.
  • The mechanisms behind persistent inflammation in chronic active MS lesions are not fully understood.

Purpose of the Study:

  • To create a high-resolution spatial and molecular atlas of immune niches within chronic active MS lesions.
  • To elucidate the role of specific immune cell interactions and metabolic pathways in sustaining neuroinflammation in MS.

Main Methods:

  • Combined single-nucleus RNA sequencing (snRNA-seq) with multiplexed error-robust fluorescence in situ hybridization (MERFISH) to map cellular and molecular features of MS lesions.
  • Utilized mouse models of experimental autoimmune encephalomyelitis (EAE) to investigate the function of microglia and lipid metabolism.
  • Genetically deleted ATP-binding cassette transporters ABCA1/G1 in microglia and pharmacologically targeted sterol metabolism.

Main Results:

  • Identified CD8+ T cell niches in lesion rims associated with inflamed microglia exhibiting interferon responses and altered lipid metabolism.
  • Deleting ABCA1/G1 in microglia led to increased lipid-storing phagocytes and amplified inflammation in EAE mice.
  • Pharmacological inhibition of sterol metabolism reduced foam cell formation and inflammatory demyelination in EAE models.

Conclusions:

  • Dysfunctional, lipid-storing microglia contribute to persistent neuroinflammation in chronic active MS lesions.
  • Targeting microglial lipid metabolism presents a potential therapeutic strategy for mitigating inflammation and demyelination in multiple sclerosis.